Organometallic Compounds
![Medchemexpress LLC Silane, [[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethyl- | 111594-58-2 | 99.6% | C40H72O2Si2 | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-250.jpg)
Medchemexpress LLC Silane, [[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethyl- | 111594-58-2 | 99.6% | C40H72O2Si2 | 100 MG
Silane, [[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- is a drug intermediate used for the synthesis of various active compounds. This product is for research use only and appears as a white to off-white solid.
- Used as a drug intermediate
- For synthesis of various active compounds
- Appears as a white to off-white solid
- For research use only
Medchemexpress LLC Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bi... | 111594-58-2 | 99.61% | C40H72O2Si2 | 500 MG
Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- is a drug intermediate for synthesis of various active compounds. It is for research use only and not sold to patients.
- Drug intermediate for synthesis of various active compounds.
- For research use only.
- Not sold to patients.
- Appearance: Solid.
- Color: White to off-white.
Medchemexpress LLC (S)-S007-1558 (GPVI antagonist 1) | 1327156-14-8 | 99.8% | C19H19N3O4S | 50 MG
(S)-S007-1558 is a potent glycoprotein VI (GPVI) platelet receptor antagonist primarily used for research purposes. This compound effectively modulates platelet activity.
- Inhibits collagen-induced platelet aggregation (IC50 of 25.3 μM)
- Solid appearance, white to off-white color
- Molecular weight of 385.44
- Ships at room temperature (continental US)
- Powder storage: -20°C for 3 years, 4°C for 2 years
- In-solvent storage: -80°C for 6 months, -20°C for 1 month
- Soluble in DMSO at concentrations ≥ 50 mg/mL
Medchemexpress LLC (S)-S007-1558 (GPVI antagonist 1) | 1327156-14-8 | 99.8% | C19H19N3O4S | 100 MG
(S)-S007-1558 is a glycoprotein VI (GPVI) platelet receptor antagonist. It inhibits collagen-induced platelet aggregation with an IC50 of 25.3 μM. This product is intended for research use only.
- Glycoprotein VI (GPVI) platelet receptor antagonist
- Inhibits collagen-induced platelet aggregation
- IC50 of 25.3 μM
- Intended for research use only
Medchemexpress LLC N-(Amino-PEG3)-N-bis(PEG4-Boc) | 2353409-57-9 | 98.0% | C38H76N2O15 | 100 MG
N-(Amino-PEG3)-N-bis(PEG4-Boc) is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. PROTACs consist of two different ligands connected by a linker; one ligand targets an E3 ubiquitin ligase, and the other targets the protein of interest. These molecules exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
- PEG-based PROTAC linker
- Utilized in PROTAC synthesis
- Applicable in cancer-programmed cell death research
- Connects two different ligands for PROTAC formation
- Targets E3 ubiquitin ligase and protein of interest
- Exploits intracellular ubiquitin-proteasome system
- Selectively degrades target proteins
eMolecules Ambeed / 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate / 250mg / 525081440 / A165302 / / 77544-68-4 / MFCD18433414 / 304.360 / C13H20O6S
Ambeed / 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate / 250mg / 525081440 / A165302 / / 77544-68-4 / MFCD18433414 / 304.360 / C13H20O6S
Medchemexpress LLC Azido-PEG3-SSPy | 98.6% | 344.45 g·mol⁻¹ | C13H20N4O3S2 | 100 MG
Azido-PEG3-SSPy is a cleavable three-unit polyethylene glycol (PEG3) linker used for assembling antibody-drug conjugates (ADCs) and general bioconjugation. It contains an azide functional group enabling copper-catalyzed azide-alkyne cycloaddition (CuAAC) and is compatible with strain-promoted azide-alkyne cycloaddition (SPAAC) with DBCO or BCN partners.
- Cleavable disulfide linker for controlled release.
- Azide-functionalized for CuAAC click chemistry.
- Compatible with SPAAC (DBCO and BCN) reactions.
- High purity suitable for conjugation workflows.
- Multiple pack sizes available for research use.
![eMolecules Broadpharm / m-PEG8-triethoxysilane / 250mg / 795361866 / BP-40222 / 95.000 / / [null] / 615.833 / C27H57NO12Si](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502472884.JPG-250.jpg)
eMolecules Broadpharm / m-PEG8-triethoxysilane / 250mg / 795361866 / BP-40222 / 95.000 / / [null] / 615.833 / C27H57NO12Si
Broadpharm / m-PEG8-triethoxysilane / 250mg / 795361866 / BP-40222 / 95.000 / / [null] / 615.833 / C27H57NO12Si
Medchemexpress LLC Atorvastatin-PEG3-FITC | 1440755-31-6 | 98.2% | C64H68FN5O12S | 10MG
Atorvastatin-PEG3-FITC is a fluorescently labeled derivative of atorvastatin used as a ligand in fluorescence anisotropy assays and reported as a KRAS-PDEδ interaction inhibitor (compound S31). It is provided for research use with defined chemical characteristics and high reported purity suitable for biochemical experiments.
- Acts as a ligand in fluorescence anisotropy assays.
- Reported to inhibit KRAS-PDEδ interaction (compound S31).
- Contains an FITC fluorescent tag for fluorescence-based detection.
- High reported purity (98.17%) suitable for biochemical assays.
- Defined molecular formula and molecular weight for assay calculations.
- Available in small research pack sizes for assay optimization.
Medchemexpress LLC Ms-PEG5-t-butyl ester | 870487-48-2 | MFCD20926382 | 95.0% | C16H32O9S | 10MG
Ms-PEG5-t-butyl ester is a PEG-based linker featuring a t-butyl-protected carboxyl group, designed for use in the chemical synthesis of PROTAC molecules. It provides a hydrophilic spacer to connect ligands while masking the carboxylate during multi-step syntheses.
- Provides a hydrophilic polyethylene glycol spacer to improve solubility.
- Contains a t-butyl-protected carboxyl group for orthogonal protection during synthesis.
- Compatible with standard coupling and deprotection chemistries used in medicinal chemistry.
- Facilitates assembly of bifunctional degraders by spacing ligands and reducing steric hindrance.
- Available in small-scale quantities suitable for research and discovery workflows.
- Reported high purity suitable for synthetic applications; verify with certificate of analysis.
Medchemexpress LLC Nh2-peg5-c6-cl hydrochloride | 2241669-16-7 | 98.0% | 5 G
NH2-PEG5-C6-Cl hydrochloride is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
- Used in the synthesis of PROTACs
- Exploits the intracellular ubiquitin-proteasome system to selectively degrade target proteins
Medchemexpress LLC THP-PEG3-OH | 60221-37-6 | 98.7% | 5 G
THP-PEG3-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
- Can be used in the synthesis of PROTACs
- Contains two different ligands connected by a linker: one for an E3 ubiquitin ligase and the other for the target protein
- Exploits the intracellular ubiquitin-proteasome system to selectively degrade target proteins
Medchemexpress LLC THP-PEG3-OH | 60221-37-6 | 98.7% | 1 G
THP-PEG3-OH is a PEG-based PROTAC linker used in the synthesis of PROTACs. This compound is intended for research use only and is not sold to patients.
- Enables the synthesis of PROTACs
- Functions as a PROTAC linker
- Utilizes the PROTAC pathway
- Facilitates selective degradation of target proteins via the ubiquitin-proteasome system
Medchemexpress LLC Pomalidomide-PEG3-C2-NH2 TFA (cereblon ligand-linker conjugates 5 TFA) | 2414913-97-4 | 99.0% | 500 MG
Pomalidomide-PEG3-C2-NH2 TFA is a synthetic E3 ligase ligand-linker conjugate. It is composed of a pomalidomide-based cereblon ligand and a 3-unit PEG linker.
- Comprises a pomalidomide-based cereblon ligand.
- Includes a 3-unit PEG linker.
- Can be used for the synthesis of PROTACs.
Medchemexpress LLC Bis-PEG3-acid | 96517-92-9 | 97.0% | 250 MG
Bis-PEG3-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
- PEG-based PROTAC linker
- Used in the synthesis of PROTACs
- Exploits the intracellular ubiquitin-proteasome system
- Selectively degrades target proteins
- Intended for research use only
- Not sold to patients
- Viscous liquid appearance
- Colorless to light yellow color